Corp. SVP BioPharma Network

Corporate Vice President

Mars, Hill’s, Zoetis Join HABRI to Chart Path Toward Sustainable Future for Veterinary Medicine

Idiopathic Pulmonary Fibrosis Diagnostic and Treatment Market Forecasts Report 2025-2030 | Boehringer Ingelheim and FibroGen Lead by Driving Innovations in Pharmacological and Diagnostic Advancements

FDA grants Hernexeos ‘Breakthrough’ status in NSCLC

Urea Cycle Disorder Treatment Market Outlook 2035: Rising to US$ 771 Mn at 3.5% CAGR | Transparency Market Research

Executive Director, ExpMED Oncology Immunotherapy

Boehringer Ingelheim is a global leader in healthcare dedicated to improving lives. They are seeking an Executive Director for Experimental Medicine Oncology Immunotherapy, responsible for providing medical strategic leadership and overseeing clinical development in oncology and immunotherapy.

Vice President, Cancer Immunology & Immune Modulation

Associate Director, Oncology

Chief Veterinary Officer

Senior Vice President, Global Head Cancer Immunology & Immune Modulation

Senior Associate Director, Medical Affairs

Sign up with Google

Sign in with Google